latest news releases from the newsroom
Magma Design Automation
SiliconBlue and Magma Strengthen Technology Partnership
SUNNYVALE, Calif. and SAN JOSE, Calif., Nov. 24, 2008 (GLOBE NEWSWIRE) -- SiliconBlue(tm) Technologies, pioneer of an Ultra-Low-Power 65-nm FPGA (Field Programmable Gate Array) technology for consumer applications, today announced it has formalized a technical partnership with Magma(r) Design Automation (Nasdaq:LAVA). The agreement facilitates close collaboration and co-development between the two companies to provide a comprehensive FPGA design environment for SiliconBlue's iCE65(tm) FPGA product line, which was introduced in June.
Honda Power Equipment
Honda Introduces the Honda Portable Power System
ALPHARETTA, Ga., Nov. 24, 2008 (GLOBE NEWSWIRE) -- Honda Power Equipment is launching the Honda Portable Power System (HP(2)S), the first portable home power backup system that provides automatic, uninterruptible and intelligent transfer of power during outages. The HP(2)S also features an innovative home security component that operates independently of power outages.
Primoris Services Corporation
Primoris Services Corporation to Present At FBR Capital Markets Fall Investor Conference
LAKE FOREST, Calif., Nov. 24, 2008 (GLOBE NEWSWIRE) -- Primoris Services Corporation (Nasdaq:PRIM) (Nasdaq:PRIMU) (Nasdaq:PRIMW) ("Primoris"), one of the largest specialty contractors and engineering companies in the United States, today announced that it is scheduled to present at the FBR Capital Markets Fall Investor Conference. This event will take place at The Grand Hyatt Hotel in New York City. Primoris is scheduled to present on Tuesday, December 2, 2008 at 10:00 AM Eastern Time.
Emisphere Technologies, Inc.
Emisphere Announces Study Results Of New, Orally Bioavailable Formulation of Parathyroid Hormone ('Pth') Using Eligen(r) Technology
CEDAR KNOLLS, N.J., Nov. 24, 2008 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS) announced today the results of a study by Novartis Pharma AG which demonstrates the achievement of a suitable PK profile of a new oral formulation of Parathyroid Hormone ("PTH") using Emisphere's Eligen(r) Technology. This initial study of 20 healthy postmenopausal female patients aged 40 to 70 years resulted in peak concentrations (CMAX) in the range of those obtained with the commercially available subcutaneous formulation Forteo (teriparatide). The plan is to continue the development program.
Entertainment Games, Inc.
eGames Announces First Quarter Fiscal 2009 Financial Results
LANGHORNE, Pa., Nov. 24, 2008 (GLOBE NEWSWIRE) -- eGames, Inc. (Pink Sheets:EGAM), a developer and publisher of games for the PC, game consoles and the Internet, today released financial results for its fiscal first quarter ended September 30, 2008.